greeksoup/ stock research

National Health Investors (NHI) FY2021 results: revenue $299 million, down 10.2% on the year

National Health Investors Inc. (NHI) reported revenue of $299 million for fiscal 2021, the year ended 31 December 2021, down 10.2% on the year before. Net income was $112 million, down 39.6%, and diluted earnings per share $2.44. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2022.

Revenue
$299 million
-10.2% on the year
FY2014FY2021
Operating margin
n/a
FY2014FY2021
Net income
$112 million
-39.6% on the year
FY2014FY2021
Diluted EPS
$2.44
-41.1% on the year
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue299333318-10.2%
Operating incomen/an/a161
Operating marginn/an/a50.7%
Interest expense50.852.956.3-3.9%
Pre-tax incomen/an/a161
Net income112185160-39.6%
Net margin37.4%55.6%50.4%
Diluted EPS$2.44$4.14$3.67-41.1%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow211232241-9.2%
Capital expenditure50.3117237-56.9%
Free cash flow1611153.8+39.1%
Free cash flow margin53.7%34.7%1.2%
Cash from investing185-89.7-343
Cash from financing-403-112107
Share-based compensation5.15.43.6-6.7%
Buybacks0.00.0n/a
Dividends paid183195180-6.0%
Dividend per share$3.80$4.41$4.20-13.8%
Diluted shares, weighted46m45m44m+2.3%
Shares outstanding at period end46m45m45m+1.5%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity1,5071,5121,498-0.3%
Non-controlling interest9.910.70.6-7.6%
Redeemable equity0.0n/an/a
Debt1,2431,4991,440-17.1%
Other liabilities79.098.3104-19.6%
Total liabilities and equity2,8393,1203,042-9.0%
Fixed assets2,3182,6672,560-13.1%
Loans300292340+2.6%
Cash and equivalents37.443.35.2-13.7%
Receivables3.22.63.2+23.7%
Other assets180115133+57.3%
Total assets2,8393,1203,042-9.0%

10-K for the year ended 31 December 2021, filed 22 February 2022: the filing.